A 24-week pilot study of dual maintenance therapy with raltegravir and lamivudine
Conclusion:
This pilot study suggests that switching to raltegravir along with lamivudine in patients with viral suppression maintains efficacy and is well tolerated. A larger study of longer duration is required to confirm these findings.
Source: AIDS - Category: Infectious Diseases Tags: CLINICAL SCIENCE: CONCISE COMMUNICATION Source Type: research
More News: Hepatitis | Hepatitis B | HIV AIDS | Infectious Diseases | Isentress | Laboratory Medicine | Science | Sleep Disorders | Sleep Medicine | Study